Debra White's most recent trade in Lucid Diagnostics Inc was a trade of 112,800 Common Stock done . Disclosure was reported to the exchange on Feb. 20, 2025.
Stock | Client Name | Client Category | Action | Reported to Exchange | Quantity | Post Transaction Holding | Traded % | Avg. Price | Value | Security Type |
---|---|---|---|---|---|---|---|---|---|---|
Lucid Diagnostics Inc | Debra J. White | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 20 Feb 2025 | 112,800 | 112,800 | - | 0 | Common Stock | |
Lucid Diagnostics Inc | Debra White | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 22 Feb 2024 | 150,000 | 150,000 | - | - | Employee stock option (right to buy) | |
PAVmed Inc | Debra White | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 22 Feb 2024 | 65,000 | 65,000 (0%) | 0% | - | Common stock | |
Lucid Diagnostics Inc | Debra White | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 31 Jan 2023 | 175,000 | 175,000 | - | - | Employee stock option (right to buy) | |
PAVmed Inc | Debra White | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 30 Jan 2023 | 450,000 | 450,000 | - | - | Employee stock option (right to buy) | |
Lucid Diagnostics Inc | Debra White | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 02 Aug 2022 | 80,000 | 80,000 | - | - | Employee stock option (right to buy) | |
PAVmed Inc | Debra White | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 18 Feb 2022 | 80,000 | 80,000 | - | - | Employee stock option (right to buy) | |
PAVmed Inc | Debra White | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 29 Apr 2021 | 100,000 | 100,000 | - | - | Employee Stock Option (Right to Buy) |